VBI Vaccines

graphic image of different colored hands shaking

Biotech

BeiGene, Brii and Ideaya ring in 2025 with deals

Ideaya wrote the biggest check, handing Jiangsu Hengrui Pharmaceuticals $75 million upfront for a DLL3-directed ADC outside of Greater China.

Nick Paul Taylor Jan 2, 2025 8:30am

unstable stay back warning

VBI Vaccines files for bankruptcy, seeks asset sale

Jul 30, 2024 10:56am

graphic art of a right hand signing something

Brii pays VBI $15M for global rights to hepB program and more

Jul 6, 2023 6:00am

Layoffs redundancies

VBI Vaccines pares down pipeline, staff to focus on hepatitis B

Apr 4, 2023 10:56am

picture of a paraglider

Agios replaces CEO after recent FDA nod—Chutes & Ladders

Jul 15, 2022 9:30am